Market News AIOpen the app

GH Research has named Dr. Vanina Popova as the new Chief Development Officer to lead its depression treatment efforts.

New bossRead the original at globenewswire.com
Good for GHRS

GH Research appointed Vanina Popova to lead GH001's clinical work. Her experience with later-stage drug development supports the next programs, though the report gives no results showing GH001 works.

GHRS · GH Research PLC

AI read · Good for GHRS

The AI's read

Her past work on Spravato gives GH Research experience connected to a depression treatment program. That may help prepare GH001 for later-stage studies. The report gives no study results, so this supports the work but does not show that GH001 works.

Get alerts for GHRS

Follow GH Research PLC (GHRS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GHRS
Free on the App Store and Google Play, or on the web.